Industry Insights
How Metabolomic Biomarker Networks Could Help Diagnose Bladder Cancer
Industry InsightWe spoke to Dr. Maximilian Zucker to learn more metabolomic biomarker networks and the role that they could play in the future of diagnostics.
Read More
Data-Driven Medicine: The Role of AI in Cancer Diagnostics
Industry InsightWe find out how SOPHiA™, a recently introduced artificial intelligence platform, could help improve the adoption of liquid biopsies in hospitals.
Read More
First FDA Approval for NGS-based Companion Diagnostic
Industry InsightTo learn about some of the challenges met in achieving FDA approval, the advantages the test offers, and how its use can benefit non-small cell lung cancer patients, we spoke to Joydeep Goswami, president of Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific.
Read More
Driving Forward Companion Diagnostics Development
Industry InsightWe spoke to Dr. Markus Tolnay and Mark Stevenson, to learn more about the NGS Companion Dx Center of Excellence Program and what it hopes to achieve.
Read More
The Role of Metabolomics in Diagnostics
Industry InsightWe spoke to Volker Pfahlert, numares AG, to learn about the role of metabolomics in diagnostics and the advantages it can offer over current methods.
Read More
Improving Prostate & Bladder Cancer Diagnosis
Industry InsightWe spoke to Nadia Whittley, CEO, Arquer Diagnostics, to learn about some of the current limitations of diagnosing bladder and prostate cancer, and how MCM5-ELISA tests could help.
Read More
Overcoming Problems in Biopharma with Mass Spectrometry
Industry InsightSCIEX have launched their new X500B QTOF Mass Spectrometry System. To find out more, and to see how the new system helps over come current problems in biophama, we spoke to Farzana Azam, Senior Director of Pharmaceutical Business at SCIEX.
Read More
High Purity Plasma Extraction
Industry InsightTo learn about some of the challenges of extracting plasma from blood, and how a recently developed microfluidic device could help overcome some of these, we spoke to Dr. Weihua Li.
Read More
A New Weapon in the War Against Antibiotic Resistance
Industry InsightWe spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.
Read More
Verification of Scientific Methods and Results
Industry InsightTo find out about the sbv IMPROVER project and its aims, we spoke to Dr Julia Hoeng, Director of Systems Toxicology at PMI Research & Development.
Read More
